抗凝剂

kànɡ nínɡ jì
  • anticoagulant;antifreeze;decoagulant
抗凝剂抗凝剂
  1. 在排除多种因素并查阅了相关资料后,推测有可能是抗凝血中抗凝剂的使用对基因组DNA的扩增效率产生影响。

    Referring to involved information and after excluding many factors , we speculated that anticoagulant in blood may impact PCR amplification efficiency .

  2. 口服抗凝剂治疗的患者仅INR能使PT的报告方式标准化。

    For patients on oral anticoagulant therapy , only INR standardized the PT results .

  3. 不同抗凝剂对PT、APTT测定结果的相关性分析

    Correlation Analysis on Different Anticoagulants in Determination of PT and APTT

  4. 可见,从凝固鹅血中提取的SOD比活力高(纯度高、活性好),且提取过程不需加抗凝剂和分离血球,工序较简单。

    Therefore , specific activity of SOD from coagulation goose blood is higher ( activity and purity is better ) .

  5. 心脏瓣膜置换术后PTINR测定监测口服抗凝剂的研究

    Research of PT INR assay during monitoring oral anticoagulants after cardiac valve replacement

  6. 透析器及血路管复用容易。结论LMWH是维持性血液透析较为理想的抗凝剂。

    Conclusions LMWH was an ideal anticoagulant for patients of maintaining hemodialysis .

  7. ②方法采用枸橼酸钠和肝素两种抗凝剂,对79例正常人和36例病人的红细胞沉降率(ESR)进行了测定。

    Methods Erythrocyte sedimentation rate ( ESR ) of79 normal controls and36 patients was determined with sodium citrate and heparin .

  8. 所有患者每日均注射小剂量抗凝剂以预防DVT和肺栓塞的发生。

    All these patients we give small daily doses of injected anti-coagulant to prevent DVT and to prevent pulmonary embolism .

  9. 另外抗凝剂,标本放置时间,技术操作误差或试剂也是仪器法计数PLT的影响因素。

    Besides , anticoagulant , sample standing time and incorrect procedure are the influence factors in the analyzer count PLT .

  10. 于末次给药后24h,摘眼球取血,与抗凝剂混匀,全自动五类多物种血液分析仪检测外周血小板计数。

    After the last administration 24h , eyeball blood , and anticoagulant mixing , automatic analysis of five multi - species detected in peripheral blood platelet count .

  11. 结论诺易平较速碧林在血透中做抗凝剂有更好的抗Xa活性及更少的出血危险性。

    Conclusion Clivarin provides a more effective anti - Xa activity and a small bleeding risk than Fraxiparine in CHD patients .

  12. 4采血量与抗凝剂比例1∶5与1∶9比较,PT、APTT测定结果差异有极显著性意义(均P<0.01)。

    There was significant difference in PT and APTT between 1 ∶ 5 of sampling volume to anticoagulants and 1 ∶ 9 ( all P < 0.01 ) .

  13. 毛细玻璃管法测定小鼠全血凝血时间(CT);比较等效抗凝剂量的VnA及肝素对小鼠尾出血时间(BT)的影响。

    Whole blood coagulation time ( CT ) in mice was measured by capillary glass tube method , bleeding time ( BT ) by hemorrhagic transection of mouse tail model .

  14. 结果肝素与EDTA·K2两种不同抗凝剂抗凝时全血中苯丙氨酸和酪氨酸测定结果比较无统计学意义(P>0.05)。

    Results The levels of phenylalanine and tyrosine in whole-blood were consistent when using EDTA · K_2 or heparin as anticoagulant ( P > 0.05 ) .

  15. 结论ACD对疟原虫的抑制性效应最为明显,SC是疟原虫试验中枸橼酸钠抗凝剂的首选。

    Conclusion ACD showed the most significant inhibitive effect on the growth of malaria parasites and SC was the best anticoagulant based on sodium citrate for malarial experiments .

  16. 结论温度和抗凝剂(EDTA-K2)对血标本的ECP水平测定有不同程度的影响。

    Conclusion Temperature and antic oagulant ( EDTA-K 2 ) can affect the ECP level in different degrees .

  17. “PNH应用抗凝剂是有风险的,尤其是当血小板记数偏低的时候。”他警告说。

    " There is a risk of anticoagulation in PNH , particularly when patients have low platelet counts ," he cautioned .

  18. 为了解决常规现场裂解猪全血时出现的血液凝结问题,提高了裂解液中抗凝剂EDTA的浓度,并对血液消化的蛋白酶K的用量作了梯度处理。

    In order to solve the problem of porcine blood condensation during the course of collection and transport , different concentration of EDTA , an antithrombotics , and gradient concentration of proteinase K were used in the experiment .

  19. 结论:不同温度下标本存放时间、离心速度、抗凝剂种类等对PT、APTT试验测定结果有影响。

    Conclusion : All the different temperatures , different times of specimen placement , different dis-persed speeds and different kinds of anticoagulation agent are the influence factors to the determination results of PT and APTT .

  20. 结论温度和抗凝剂对血ECP水平有显著影响,37℃凝集为ECP水平测定的最适温度,日常工作中应制定相应温度下的正常参考值。

    Conclusion Temperature and anti-coagulation ( EDTA-K_2 ) affected the ECP level , and 37 ℃ was the best temperature for determining it . Therefore the reference values for different temperature should be established .

  21. 方法对4例(4眼)ARN患者采用无环鸟苷、糖皮质激素、抗凝剂和改善微循环等治疗,同时手术治疗其视网膜脱离。

    Methods 4 cases with ARN were treated by acyclovir , glucocorticoid , anticoagulant and microcirculation improvement , and operative treatment for their retinal detachment .

  22. 结论新生儿生理性抗凝血因子处于一个较低的水平,α2-MG正常可能是一种代偿机制。在新生儿出血性疾病的诊断及抗凝剂的应用中应引起注意。

    Conclusion Anticoagulant functions were at a lower level and the level of α _2-MG maybe one saving mechanism which provides a information for diagnoses of neonatal hemorrhagic diseases and use of anticoagulant in clinic .

  23. 目的:本文介绍以乙二胺四乙酸盐EDTA-K2为抗凝剂,制备一次性微量抗凝管,用以替代进口抗凝管。

    Objection : This paper introduces a method to use EDTA-K 2 as anticoagulant reagent makes micro-anticoagulant tubes for once to replace import ones .

  24. 减少抗凝剂剂量,预防出血倾向;

    Decreasing the dose of anticoagulant and preventing of hemorrhagic tendency ;

  25. 抗凝剂防治缺血性脑卒中的临床证据

    Clinical Evidence of Anticoagulants in Ischaemic Stroke Prevention and Treatment

  26. 应用抗凝剂的心脏瓣膜置换患者接受胆道手术的术前处理

    Preoperative management of anticoagulated valve replacement patient undergoing selective biliary tract surgery

  27. 抗凝剂浓度过高会造成腐蚀损坏的水通道。

    Excessive antifreeze concentration can cause corrosion damage in the water passages .

  28. 氟化钠-EDTA二钾联合抗凝剂在血糖检测中的应用

    Use of sodium fluoride-EDTA-K2 joint anticoagulant in blood glucose detection

  29. 抗凝剂的含量对血细胞参数的影响探讨

    Studying the effect of the content of anticoagulant to blood cell parameters

  30. 肝素为最广泛应用及最可靠的抗凝剂。

    Heparin is the most widely used and reliable anticoagulant .